Recent PTAB Decision Highlights Importance of Secondary Considerations in Obviousness Challenges

Jun 2, 2017

Reading Time : 1 min

By: Rubén H. Muñoz, Lance Han, law clerk (not admitted to practice)

The patent at issue in Varian Medical Systems is U.S. Pat. No. 7,471,765 B2 (the “’765 patent”), which generally relates to using a cone-beam CT scanner with a flat-panel imager in conjunction with a radiation therapy system as an image-guided radiotherapy system for increased precision and effectiveness of radiation treatments. The petitioners argued, and the PTAB agreed, that all claim limitations were taught by the combination of prior art references. However, the PTAB also assessed “secondary considerations” in its obviousness inquiry. In doing so, the PTAB found “(1) very strong evidence of industry praise; (2) very strong evidence of long-felt need; (3) moderately strong evidence of commercial success; and (4) moderately strong evidence of copying,” pointing to the nonobvious nature of the ’765 patent and its claims. First, for industry praise, the PTAB found evidence of textbook publications praising the invention, journal publications (“more than 1,000 . . . scientific articles”) citing the invention, and an R&D award from a magazine in 2006. Second, for long-felt need, the PTAB analyzed evidence such as the patent owner’s declaration and deposition testimony, and a journal publication that supported the patent owner’s assertion that the problem the patent purported to solve “need[ed] to be solved, and that it was long-felt at least since ‘the early 1990s.’”  Third, for commercial success, the PTAB found evidence that the majority of sales both worldwide and in North America were made with the claimed invention. Lastly, for copying, the PTAB found evidence that a third party created a product that met all claim limitations.

As a result, despite finding that the prior art, and the combinations of those prior art references, were “well known to one of ordinary skill in the art,” the PTAB ruled that the patent owner’s evidence of secondary considerations, which strongly pointed to nonobviousness, outweighed those findings and thus rejected the petitioner’s obviousness challenge.

Varian Medical Systems, Inc. v. William Beaumont Hospital, IPR2016-00162, Paper 69 (May 4, 2017).

Share This Insight

Previous Entries

IP Newsflash

November 17,2025

The district of Delaware recently denied a defendant’s partial motion to dismiss pre-suit willful infringement from the litigation, finding instead that the allegations taken as a whole were sufficient to support pre-suit willfulness at the pleading stage. Specifically, the court found that the allegations as to the defendant’s involvement in a related foreign opposition proceeding and participation in the relevant industry were accompanied by detailed factual support that sufficiently pleaded willful infringement for the pre-suit period.

...

Read More

IP Newsflash

November 14, 2025

The Ninth Circuit recently reversed a district court’s decision to strike a plaintiff’s trade secret claims under the Defend Trade Secrets Act (DTSA) at the discovery stage. In doing so, the Ninth Circuit made clear that under the DTSA, whether a party defined their trade secret with sufficient particularity is a question of fact that generally does not lend itself to resolution in the absence of at least some discovery. This ruling contrasts with the California Uniform Trade Secrets Act (CUTSA), which requires a party to define their trade secrets with reasonable particularity before commencing discovery.

...

Read More

IP Newsflash

November 11, 2025

The Federal Circuit recently vacated a summary judgment ruling of invalidity, holding that the district court erred in applying preclusive effect to the Patent Trial and Appeal Board’s unpatentability findings regarding other claims in the same patent. In doing so, the Federal Circuit reiterated that issue preclusion does not apply where the prior factual determinations were made under a lower standard of proof.

...

Read More

IP Newsflash

November 3, 2025

The Federal Circuit recently clarified the requirement for work disclosed in a reference to qualify as “by another” under pre-AIA Sections 102(a) and (e), holding that there must be complete inventive identity between the information disclosed in the asserted reference and the inventors named on the relevant patent. 

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.